Logo image of DGNX

DIGINEX LTD (DGNX) Stock Fundamental Analysis

USA - NASDAQ:DGNX - KYG286871044 - Common Stock

9.4 USD
+0.6 (+6.82%)
Last: 9/12/2025, 8:00:01 PM
9.39 USD
-0.01 (-0.11%)
After Hours: 9/12/2025, 8:00:01 PM
Fundamental Rating

2

Taking everything into account, DGNX scores 2 out of 10 in our fundamental rating. DGNX was compared to 280 industry peers in the Software industry. While DGNX seems to be doing ok healthwise, there are quite some concerns on its profitability. DGNX is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year DGNX has reported negative net income.
DGNX had a negative operating cash flow in the past year.
DGNX Yearly Net Income VS EBIT VS OCF VS FCFDGNX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2022 2023 2024 2025 -2M -4M -6M -8M -10M

1.2 Ratios

DGNX has a worse Return On Assets (-102.10%) than 91.43% of its industry peers.
The Return On Equity of DGNX (-139.85%) is worse than 80.00% of its industry peers.
Industry RankSector Rank
ROA -102.1%
ROE -139.85%
ROIC N/A
ROA(3y)-388.73%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
DGNX Yearly ROA, ROE, ROICDGNX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2022 2023 2024 2025 0 -200 -400 -600 -800

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for DGNX so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
DGNX Yearly Profit, Operating, Gross MarginsDGNX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2022 2023 2024 2025 -200 -400 -600 -800 -1K

More info and screens

6

2. Health

2.1 Basic Checks

DGNX does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for DGNX has been increased compared to 1 year ago.
Compared to 1 year ago, DGNX has an improved debt to assets ratio.
DGNX Yearly Shares OutstandingDGNX Yearly Shares OutstandingYearly Shares Outstanding 2022 2023 2024 2025 5M 10M 15M 20M
DGNX Yearly Total Debt VS Total AssetsDGNX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2022 2023 2024 2025 5M 10M 15M 20M

2.2 Solvency

DGNX has an Altman-Z score of 605.55. This indicates that DGNX is financially healthy and has little risk of bankruptcy at the moment.
DGNX has a better Altman-Z score (605.55) than 99.64% of its industry peers.
A Debt/Equity ratio of 0.02 indicates that DGNX is not too dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.02, DGNX is in the better half of the industry, outperforming 61.43% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.02
Debt/FCF N/A
Altman-Z 605.55
ROIC/WACCN/A
WACC11.16%
DGNX Yearly LT Debt VS Equity VS FCFDGNX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2022 2023 2024 2025 0 10M -10M -20M

2.3 Liquidity

DGNX has a Current Ratio of 3.79. This indicates that DGNX is financially healthy and has no problem in meeting its short term obligations.
With an excellent Current ratio value of 3.79, DGNX belongs to the best of the industry, outperforming 82.86% of the companies in the same industry.
A Quick Ratio of 3.79 indicates that DGNX has no problem at all paying its short term obligations.
Looking at the Quick ratio, with a value of 3.79, DGNX belongs to the top of the industry, outperforming 82.86% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 3.79
Quick Ratio 3.79
DGNX Yearly Current Assets VS Current LiabilitesDGNX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2022 2023 2024 2025 5M 10M

More info and screens

3

3. Growth

3.1 Past

DGNX shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -116.03%.
Looking at the last year, DGNX shows a very strong growth in Revenue. The Revenue has grown by 31.84%.
DGNX shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 22.13% yearly.
EPS 1Y (TTM)-116.03%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-53.49%
Revenue 1Y (TTM)31.84%
Revenue growth 3Y22.13%
Revenue growth 5YN/A
Sales Q2Q%57.03%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
DGNX Yearly Revenue VS EstimatesDGNX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2022 2023 2024 2025 500K 1M 1.5M 2M

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

DGNX reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
DGNX Price Earnings VS Forward Price EarningsDGNX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
DGNX Per share dataDGNX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -0.1 -0.2 -0.3

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

DGNX does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

DIGINEX LTD

NASDAQ:DGNX (9/12/2025, 8:00:01 PM)

After market: 9.39 -0.01 (-0.11%)

9.4

+0.6 (+6.82%)

Chartmill FA Rating
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)07-12 2025-07-12
Earnings (Next)N/A N/A
Inst Owners0.31%
Inst Owner ChangeN/A
Ins Owners8.69%
Ins Owner ChangeN/A
Market Cap1.73B
AnalystsN/A
Price TargetN/A
Short Float %N/A
Short Ratio1.4
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 675.07
P/FCF N/A
P/OCF N/A
P/B 379.36
P/tB 379.36
EV/EBITDA N/A
EPS(TTM)-0.38
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.04
FCFYN/A
OCF(TTM)-0.04
OCFYN/A
SpS0.01
BVpS0.02
TBVpS0.02
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -102.1%
ROE -139.85%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-388.73%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover0.41
Health
Industry RankSector Rank
Debt/Equity 0.02
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 3.79
Quick Ratio 3.79
Altman-Z 605.55
F-Score3
WACC11.16%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-116.03%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-53.49%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)31.84%
Revenue growth 3Y22.13%
Revenue growth 5YN/A
Sales Q2Q%57.03%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-5.43%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-30.98%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-30.98%
OCF growth 3YN/A
OCF growth 5YN/A